Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	104.76B
Revenue (ttm)	55.55B
Net Income (ttm)	2.36B
Shares Out	n/a
EPS (ttm)	2.04
PE Ratio	44.37
Forward PE	10.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,322,629
Average Volume	1,397,098
Open	9,164.00
Previous Close	9,071.00
Day's Range	9,151.00 - 9,406.00
52-Week Range	4,865.00 - 9,406.00
Beta	0.70
RSI	75.21
Earnings Date	Jan 28, 2026

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 35,686
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

In 2024, TLV:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD